|
US2010028264A1
|
|
LTBP2 as a biomarker and diagnostic target
|
|
US2008050315A1
|
|
Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1)
|
|
US2007253949A1
|
|
Diagnostics and Therapeutics for Diseases Associated with Plasma Kallikrein (KLKB1)
|
|
US2006292155A1
|
|
Diagnostics and therapeutics for diseases associated with mosaic serine protease (msp)
|
|
US2007037226A1
|
|
Diagnostics and therapeutics for diseases associated with G-protein coupled receptor AdipoR1(AdipoR1)
|
|
US2006240436A1
|
|
Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar)
|
|
US2006014147A1
|
|
Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
|
